Time after TACE (days)
|
Patients with nausea [cases (%)]
|
P
|
Severity of nausea [cases (%)]
|
P
|
---|
Placebo-acupuncture group
|
Active-acupuncture group
|
---|
Placebo-acupuncture group
|
Acupu-ncture group
|
Degree 1
|
Degree 2
|
Degree 3
|
Degree 1
|
Degree 2
|
Degree 3
|
---|
0
|
34 (48.6)
|
26 (36.1)
|
0.133
|
36 (51.4)
|
22 (31.4)
|
12 (17.1)
|
46 (63.9)
|
19 (26.4)
|
7 (9.7)
|
0.256
|
1
|
30 (42.9)
|
26 (36.1)
|
0.411
|
40 (57.1)
|
20 (28.6)
|
10 (14.3)
|
46 (63.9)
|
15 (20.8)
|
11 (15.3)
|
0.562
|
2
|
30 (42.9)
|
28 (38.9)
|
0.631
|
40 (57.1)
|
18 (25.7)
|
12 (17.1)
|
44 (61.1)
|
21 (29.2)
|
7 (9.7)
|
0.426
|
3
|
21 (30.0)
|
22 (30.1)
|
0.943
|
49 (70.0)
|
15 (21.4)
|
6 (8.6)
|
50 (69.4)
|
16 (22.2)
|
6 (8.3)
|
0.993
|
4
|
19 (27.1)
|
17 (23.6)
|
0.629
|
51 (72.9)
|
16 (22.9)
|
3 (4.3)
|
55 (76.4)
|
13 (18.1)
|
4 (5.6)
|
0.750
|
5
|
14 (20.0)
|
13 (18.0)
|
0.768
|
56 (80.0)
|
12 (17.1)
|
2 (2.9)
|
59 (81.9)
|
9 (12.5)
|
4 (5.6)
|
0.564
|
- Degree1: No nausea; degree 2: very mild to moderate nausea; degree 3: severe to intolerable nausea
-
TACE transcatheter arterial chemoembolization